Left Ventricular Assist Device Percutaneous Deactivation With a Watchman Device

Tanous Aoun; Guillaume Baudry; Gilles Rioufol; Jean Francois Obadia; Matteo Pozzi

doi:10.1016/j.athoracsur.2020.11.051

Left Ventricular Assist Device Percutaneous Deactivation With a Watchman Device

Ann Thorac Surg. 2021 Aug;112(2):e127-e129. doi: 10.1016/j.athoracsur.2020.11.051. Epub 2021 Jan 11.

Authors

Tanous Aoun¹, Guillaume Baudry², Gilles Rioufol², Jean Francois Obadia¹, Matteo Pozzi³

Affiliations

¹ Department of Cardiac Surgery, Louis Pradel Cardiology Hospital, Lyon, France.
² Department of Cardiology, Louis Pradel Cardiology Hospital, Lyon, France.
³ Department of Cardiac Surgery, Louis Pradel Cardiology Hospital, Lyon, France. Electronic address: mpozzi1979@gmail.com.

PMID: 33444577
DOI: 10.1016/j.athoracsur.2020.11.051

Abstract

Myocardial recovery in patients with left ventricular assist devices is a rare event. Surgical explantation remains a risky and challenging procedure. Alternative percutaneous techniques could represent an effective solution. This report describes the clinical use of a Watchman closure device (Boston Scientific Corp, Marlborough, MA) in deactivation of a HeartMate 3 left ventricular assist device (Abbott Laboratories, Abbott Park, IL).

Publication types

Case Reports

MeSH terms

Adult
Device Removal / methods*
Fluoroscopy
Heart Failure / diagnosis
Heart Failure / physiopathology
Heart Failure / surgery*
Heart-Assist Devices*
Humans
Male
Time Factors
Tomography, X-Ray Computed
Ventricular Function, Left / physiology*